{"name":"Symplmed Pharmaceuticals LLC","slug":"symplmed-pharmaceuticals-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"XOMA 985","genericName":"XOMA 985","slug":"xoma-985","indication":"Inflammatory bowel disease (IBD)","status":"phase_3"}]}],"pipeline":[{"name":"XOMA 985","genericName":"XOMA 985","slug":"xoma-985","phase":"phase_3","mechanism":"XOMA 985 is a monoclonal antibody that targets and inhibits IL-15, a key cytokine involved in immune cell activation and proliferation.","indications":["Inflammatory bowel disease (IBD)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPemYtSUxmQktQWVQ1MlJQaERUd3R1a0ZoVjMyMi1SWnhmLXFjbk00TFNWMVczZ2RVV0FINllCa0RhZnFZUnB0TEhhQ2Y5UWhzQXFWaFJ6NWhtTGhxT0FvQS1VczhFQnhnV09uQTNnZGk5TlpGTEVSQlB5R2hFcVJ3NDJXV29heXVsdTlUbnBNUUM1cnVkVHRVdUxnRTM0ZE0?oc=5","date":"2018-03-16","type":"pipeline","source":"bendbulletin.com","summary":"Bend software firm lands cannabis-related government contract - bendbulletin.com","headline":"Bend software firm lands cannabis-related government contract","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}